We are live on ! Find out more
PTLA

Portola Pharmaceuticals, Inc.
PTLA

Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of PTLA yet.

PTLA Hedge Fund Activity: Q3 2020 in Review

0 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q3 2020, worth a combined $0 — down 100% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 162 funds closed out of PTLA and 0 opened new positions — a net loss of 162 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $126M sold.

  • 0 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q3 2020, down from 162 in Q2 2020.
  • Funds reported $0 of Portola Pharmaceuticals, Inc. stock for Q3 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Portola Pharmaceuticals, Inc. positions in Q3 2020 and 162 closed out, a net change of -162 holders.
  • The largest Portola Pharmaceuticals, Inc. seller in Q3 2020 was Vanguard Group, an estimated $126M sold.

Based on aggregated 13F filings for Q3 2020.